X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Abbott India - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs ABBOTT INDIA - Comparison Results

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS ABBOTT INDIA DR. DATSONS LABS/
ABBOTT INDIA
 
P/E (TTM) x -10.9 43.8 - View Chart
P/BV x 0.2 10.9 1.5% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 DR. DATSONS LABS   ABBOTT INDIA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
ABBOTT INDIA
Mar-16
DR. DATSONS LABS/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs1266,015 2.1%   
Low Rs313,707 0.8%   
Sales per share (Unadj.) Rs133.01,236.9 10.8%  
Earnings per share (Unadj.) Rs0.2122.2 0.1%  
Cash flow per share (Unadj.) Rs6.6129.0 5.1%  
Dividends per share (Unadj.) Rs035.00 0.0%  
Dividend yield (eoy) %00.7 0.0%  
Book value per share (Unadj.) Rs128.8521.2 24.7%  
Shares outstanding (eoy) m31.6621.25 149.0%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.63.9 15.0%   
Avg P/E ratio x516.139.8 1,297.3%  
P/CF ratio (eoy) x11.837.7 31.4%  
Price / Book Value ratio x0.69.3 6.5%  
Dividend payout %028.6 0.0%   
Avg Mkt Cap Rs m2,477103,296 2.4%   
No. of employees `000NA3.0 0.0%   
Total wages/salary Rs m563,370 1.7%   
Avg. sales/employee Rs ThNM8,891.8-  
Avg. wages/employee Rs ThNM1,140.0-  
Avg. net profit/employee Rs ThNM878.3-  
INCOME DATA
Net Sales Rs m4,21126,284 16.0%  
Other income Rs m79504 15.6%   
Total revenues Rs m4,28926,789 16.0%   
Gross profit Rs m5693,665 15.5%  
Depreciation Rs m204144 141.6%   
Interest Rs m4308 5,311.1%   
Profit before tax Rs m134,017 0.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m61,421 0.4%   
Profit after tax Rs m52,596 0.2%  
Gross profit margin %13.513.9 96.8%  
Effective tax rate %48.035.4 135.8%   
Net profit margin %0.19.9 1.2%  
BALANCE SHEET DATA
Current assets Rs m6,85214,446 47.4%   
Current liabilities Rs m6,7114,725 142.0%   
Net working cap to sales %3.337.0 9.1%  
Current ratio x1.03.1 33.4%  
Inventory Days Days16151 312.9%  
Debtors Days Days31820 1,628.4%  
Net fixed assets Rs m3,6731,113 330.0%   
Share capital Rs m317213 149.0%   
"Free" reserves Rs m3,76110,808 34.8%   
Net worth Rs m4,07811,076 36.8%   
Long term debt Rs m1,6710-   
Total assets Rs m12,63316,241 77.8%  
Interest coverage x1.0497.0 0.2%   
Debt to equity ratio x0.40-  
Sales to assets ratio x0.31.6 20.6%   
Return on assets %3.416.0 21.5%  
Return on equity %0.123.4 0.5%  
Return on capital %7.736.3 21.1%  
Exports to sales %22.90.6 3,723.9%   
Imports to sales %14.312.6 113.1%   
Exports (fob) Rs m964162 596.5%   
Imports (cif) Rs m6023,322 18.1%   
Fx inflow Rs m964268 359.7%   
Fx outflow Rs m6073,927 15.5%   
Net fx Rs m357-3,659 -9.8%   
CASH FLOW
From Operations Rs m1,3452,514 53.5%  
From Investments Rs m-2,256-800 282.1%  
From Financial Activity Rs m-1,200-803 149.4%  
Net Cashflow Rs m-2,111912 -231.5%  

Share Holding

Indian Promoters % 4.5 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 0.0 7.9 -  
FIIs % 1.4 0.1 1,350.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 17.1 550.3%  
Shareholders   20,807 18,270 113.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  FULFORD INDIA  ALKEM LABORATORIES  AJANTA PHARMA  

Compare DR. DATSONS LABS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; PSU & Healthcare Stocks Top Losers(09:30 am)

Asian equities are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 1.20% while the Hang Seng is up 0.61%. The Shanghai Composite is trading up by 0.45%.

Related Views on News

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

Khadim India Ltd. (IPO)

Oct 31, 2017

Should you subscribe to the IPO of Khadim India Ltd?

Mahindra Logistics Ltd. (IPO)

Oct 28, 2017

Should you subscribe to the IPO of Mahindra Logistics Ltd?

Godrej Agrovet Ltd. (IPO)

Oct 4, 2017

Should you subscribe to the IPO of Godrej Agrovet Limited?

Matrimony.com (IPO)

Sep 11, 2017

Should you subscribe to the IPO of Matrimony.com?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS